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Abstract 
 
Ocular inflammation from various causes may have similar clinical presentation thus careful clinical evaluations are 
mandatory particularly when the disease appear to be resistant to treatment. This paper reports a case of ocular 
lymphoma which was initially treated as Vogt Koyanagi Harada disease at a different centre. A 65-year-old 
Sudanese man complained of gradual worsening left eye vision. Careful ocular and slit lamp examination revealed a 
conjunctival lesion with choroidal infiltration as well as exudative retinal detachment. Computed tomography scan 
(CT scan) showed left eye axial proptosis, and a homogenous enhancing mass at the posterior coat of the globe. 
Tissue biopsy of the conjunctival lesion revealed marginal Zone B cell (MALT type), low grade, non-Hodgkin’s 
lymphoma. AS the ocular signs and symptoms progressed, chemotherapy was initiated. The proptosis, exudative 
retinal detachment, disc hyperemia and swelling improved after chemotherapy. The post treatment CT scan showed 
reduction of the posterior ocular coat mass. The possibility of malignant lymphoma should be considered in patients 
with resistant uveitis despite administration of corticosteroid. Ocular lymphoma is an indolent tumour with good 
prognosis. Careful ocular examination, adequate imaging studies followed by early surgical biopsy will contribute to 
early diagnosis. 
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Introduction 
 
About 5 to 10% of extranodal lymphomas are orbital 
lymphomas. They are uncommon, making up only 1% 
of all non-Hodgkin’s lymphoma (1,2). However, in 
adults aged 60 years and older, the most common 
primary orbital tumour is lymphoma (3).  
 
Extranodal marginal-zone B-cell lymphomas of 
mucosa-associated lymphoid tissue (MALT) 
lymphomas are the majority of orbital or conjunctival 
non-Hodgkin’s lymphomas (4). Primary uveal 
lymphoma  which is usually unilateral is quite an 
uncommon disease. On the other hand, primary 
vitreoretinal lymphoma can invade the central nervous  
 
 
system (CNS) due to its aggressive nature and may be 
bilateral (5). 
 
Palpebral swelling, blepharoptosis, proptosis, tumour 
formation and diplopia are among the features of 
primary malignant lymphoma (6). Orbital lymphoma 
can either be a primary disease or secondary from 
systemic lymphoma. Knowles et al. (7) reported that 
systemic lymphoma was associated with orbital 
lymphoma in 35% of cases, involving the conjunctiva 
in 20% of cases and eyelid in 67% of cases. Systemic 
lymphoma can develop in patients with solely orbital 
disease even after several years.  
Case Report 
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Figure 1: (a) Proptosis with bilateral upper lid fullness (b) Conjunctival salmon patch underneath the upper lid (c) Multiple 
choroidal infiltrates in the right fundus (d) B-scan showing a thickened choroid and retinal detachment (e) CT Scan of the orbit 
revealing a left axial proptosis with a homogenous enhancing mass at the posterior aspect of the globe (f) Left fundus shows a 
swollen optic disc and a choroidal mass 
 
This is a case report of a successfully managed case of 
primary uveal lymphoma with conjunctival and orbital 
extension, initially masquerading an ocular 
inflammatory disorder, i.e. Vogt Koyanagi Harada 
disease. This case highlights the importance of early 
detection and diagnosis of masquerade syndrome in 
elderly patients. 
 
Case Report 
 
A 65-year-old Sudanese male was referred to 
Universiti Kebangsaan Malaysia Medical Centre 
(UKMMC), Eye Centre with a provisional diagnosis 
of Vogt Koyanagi Harada disease of the left eye. Prior 
to presentation, he had been on 6 months of oral 
prednisolone for painless red left eye and progressive 
blurring of vision. Unfortunately, despite treatment, 
his condition did not improve. He denied any other 
ocular or systemic symptoms. He had no significant 
past medical, ocular, family or drug history. On 
presentation, his right visual acuity was 6/9 N5 and 
left visual acuity was CF N48. There was no relative 
afferent papillary defect detected. Intraocular pressure 
was 16 mmHg in both eyes. His left eye was noted to 
be proptosed (Fig. 1a) and there were fullness of the 
upper lids bilaterally. Further careful evaluation 
revealed conjunctiva salmon patch lesions underneath 
both upper lids (Fig. 1b).  
 
On funduscopy, the right fundus revealed multiple 
choroidal infiltrations with mild optic disc swelling 
(Fig. 1c). Unfortunately, patient also had left eye dense 
cataract which obstructed his fundus view. However, 
the B-scan ultrasound investigation of the left eye 
showed a thickened choroid with retinal detachment 
(Fig. 1d). Systemic examination was normal. Based on 
these findings, a diagnosis of bilateral ocular 
lymphoma was made.  
 
Further blood investigations performed were 
unremarkable. CT scan of the orbit confirmed a left 
axial proptosis, and showed a homogenous enhancing 
mass at the posterior aspect of the globe (Fig. 1e). 
Additional CT brain, abdomen, thorax and bone  
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Figure 2: (a) Left conjunctival salmon patch appear to have increased in size (b) Worsening of left optic disc swelling with a 
development of an inferior exudative retinal detachment (c) Development of an inferior exudative retinal detachment on B-Scan 
(d) Improvement of optic disc hyperaemia with development of subretinal fibrosis after chemotherapy (e) Improvement of the left 
axial proptosis with reduction of the mass posterior to the globe after chemotherapy 
 
marrow biopsy were normal. Tissue biopsy of the 
conjunctival lesion revealed marginal zone B-cell 
(MALT type), low-grade, non-Hodgkin’s lymphoma, 
which confirmed the diagnosis. He was then referred 
to the Haematology team who initially decided on 
conservative management at that time. He underwent 
an uncomplicated left extracapsular cataract extraction 
with intraocular lens (IOL) implantation. However, his 
left eye vision did not improve. 
 
The fundus photograph after surgery better 
demonstrates his left swollen optic disc and choroidal 
lesion affecting the macula (Fig. 1f).  
 
He was initially observed over a 6 months period. 
However, the conjunctival lesion became more injected 
and swollen (Fig. 2a) and the left optic disc became 
more hyperaemic and swollen although his vision 
remained the same. He also developed an inferior 
exudative retinal detachment (Fig. 2b & Fig.  2c).  
 
At this stage he was then commenced on 
chemotherapy (Rituximab, Cyclophosphamide, 
Vincristine, Prednisolone) by the Haematology team 
which improved the proptosis, exudative retinal 
detachment and disc hyperaemia and swelling (Fig. 
2d). The post treatment CT also showed reduction of 
the posterior ocular coat mass (Fig. 2e). 
 
To date, this patient remains well. His vision is stable 
and repeat CT scans thereafter reveals no evidence of 
recurrences. 
 
Discussion 
 
Non-Hodgkin’s lymphoma of the orbit is uncommon, 
involving only 1% of cases. Approximately, 90% and 
50-78% of all primary eye lymphomas are ocular 
adnexal marginal zone B-cell (MALT type) lymphoma 
in Japan and Korea, and Western countries 
respectively (8). 
 
Lymphoid tumours in the conjunctiva can be an 
isolated lesion or part of systemic lymphoma 
manifestation (9). Knowles et al. (7) reported that 
systemic lymphoma was associated with orbital 
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lymphoma in 35% of cases, with conjunctival 
lymphoma in 20% of cases, and with eyelid lymphoma 
in 67% of cases.  
 
At presentation, the orbit (40%) is the most commonly 
involved tissue, the conjunctiva is involved in 35-40% 
of cases, 10-15% in the lacrimal gland and 10% 
involving the eyelid. Only 10-15% of cases are 
bilateral. The term ‘salmon patch’ is widely used as 
clinically, the lesion is comparable to that of smoked 
salmon; as it is a pink, diffuse and slightly raised 
infiltrate in the stroma or underneath the Tenon’s 
fascia at the fornices (10). 
 
Systemic lymphoma can develop in patients with 
solely orbital disease even after several years. Several 
studies have shown the risk of developing systemic 
lymphoma after 5 and 10 years is around 30% and 
79% respectively (11,12). Bilateral orbital 
involvement, eyelid and lacrimal gland lymphoma 
were significant factors for the development of 
systemic lymphoma (11). Besides that, high number of 
tumours as well as location of the tumour at an 
extralimbal site (fornix or midbulbar conjunctiva) are 
also predictive of systemic lymphoma (12). 
 
Patients with uveitis at extreme age and non 
responsive to corticosteroids should be suspected to 
have masquerade syndrome. In tertiary uveitis centres, 
2-3% of all patients seen have neoplastic masquerade 
syndromes. The commonest cause of neoplastic 
masquerade syndromes is primary CNS lymphoma 
(PCNSL), of which 98% are non-Hodgkin’s B-cell 
lymphoma (13). 
 
At presentation, the disease may be unilateral however 
after several months bilateral involvement may be 
seen. Anterior examination of the eye with slit-lamp 
biomicroscopy often shows keratic precipitates on 
corneal endothelium, mild anterior segment 
inflammation, with aqueous cells and flare, and rarely 
pseudohypopyon. Chorioretinal infiltration without 
cystoid macular edema, vasculitis with perivascular 
sheathing of retinal vessels, disc edema, and exudative 
retinal detachments with variable degree of vitritis 
may be seen. 
 
In all cases of suspected orbital lymphoma, tissue 
biopsy of the lesion is mandatory to confirm the 
diagnosis. It is usually difficult to differentiate benign 
and malignant lymphoid tumour clinically. Presence of 
systemic lymphoma must be excluded via a thorough 
systemic evaluation. On histopathological 
examination, layers of lymphocytes are seen and 
categorised as malignant lymphoma or ‘reactive 
lymphoid hyperplasia’. Commonly, it is B-cell 
lymphoma and T-cell lymphoma is rarely noted (14). 
There are 2 types of ocular lymphomas; Primary 
vitreoretinal lymphoma and primary uveal lymphoma. 
Primary vitreoretinal lymphoma is common and 
maybe bilateral. It can invade the CNS due to its 
aggressive nature (5). It typically presents with 
significant vitritis unresponsive to immunosuppressant 
with variable amount of retinal or uveal involvement. 
It is of large B-cell tumour in origin and ocular disease 
usually precedes CNS disease. Early accurate 
diagnosis and treatment allows improved prognosis. 
 
In contrast, primary uveal lymphoma is generally 
unilateral and rare. In the literature, there had been 
only 60 to 80 cases reported (5). This disease is said to 
occur as a result of proliferation of low grade 
malignant histiocytes and lymphocytes in the 
choroidal tissue with subsequent involvement of 
conjunctiva or orbital tissues. However, MALT 
lymphoma arising from the conjunctiva with 
secondary uveal infiltration was recently published in 
a report (5). The diagnosis of primary uveal lymphoma 
can only be made after excluding systemic 
involvement at presentation as well as 
histopathological confirmation of the lesion. As 
illustrated in our patient’s case, the biopsy of the 
salmon patch underneath our patient’s left upper eyelid 
was done immediately upon diagnosis which 
confirmed the diagnosis of low grade, marginal zone 
B-cell (MALT type), non-Hodgkin’s lymphoma. 
 
Orbital lymphomas are indolent tumours which are 
normally localised (stage I E, Ann Arbor Staging 
System) and have good response to local radiotherapy 
or chemotherapy with favourable outcome. Various 
treatment options are available for these patients. 
Currently, there are only specific management plan for 
primary gastric MALT lymphoma. Meanwhile, for 
ocular lymphoma, the effectiveness surgical 
intervention, radiotherapy and chemotherapy are 
reported with no significant survival difference (15). 
 
Conclusion  
 
It is important to have a high index of suspicion in 
uveitis patients who are non responsive to 
corticosteroids, especially in the extreme age group as 
the diagnosis of malignancy might be delayed. 
Systemic lymphoma can develop in patients with 
solely orbital disease even after several years. 
Therefore, patients with orbital lymphoma should have 
a long term systemic multidisciplinary follow-up. 
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